ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-function

EMBO Rep. 2022 Aug 3;23(8):e54234. doi: 10.15252/embr.202154234. Epub 2022 Jun 23.

Abstract

Mutations in the human kinesin family member 5A (KIF5A) gene were recently identified as a genetic cause of amyotrophic lateral sclerosis (ALS). Several KIF5A ALS variants cause exon 27 skipping and are predicted to produce motor proteins with an altered C-terminal tail (referred to as ΔExon27). However, the underlying pathogenic mechanism is still unknown. Here, we confirm the expression of KIF5A mutant proteins in patient iPSC-derived motor neurons. We perform a comprehensive analysis of ΔExon27 at the single-molecule, cellular, and organism levels. Our results show that ΔExon27 is prone to form cytoplasmic aggregates and is neurotoxic. The mutation relieves motor autoinhibition and increases motor self-association, leading to drastically enhanced processivity on microtubules. Finally, ectopic expression of ΔExon27 in Drosophila melanogaster causes wing defects, motor impairment, paralysis, and premature death. Our results suggest gain-of-function as an underlying disease mechanism in KIF5A-associated ALS.

Keywords: ALS; KIF5A; aggregation; autoinhibition; microtubules.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Amyotrophic Lateral Sclerosis* / genetics
  • Amyotrophic Lateral Sclerosis* / metabolism
  • Animals
  • DNA, Antisense / genetics
  • Drosophila melanogaster
  • Gain of Function Mutation
  • Humans
  • Kinesins / genetics
  • Motor Neurons / metabolism
  • Mutation
  • Transcription Factor 7-Like 2 Protein / metabolism

Substances

  • DNA, Antisense
  • KIF5A protein, human
  • Tcf7l2 protein, rat
  • Transcription Factor 7-Like 2 Protein
  • Kinesins